Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.

Heart failure (HF) is the leading cause of morbidity and mortality in the industrialized world. While the transcriptomic changes in end-stage failing myocardium have received much attention, no information is available on the gene expression patterns associated with the development of HF in large mammals. Therefore, we used a well-controlled canine model of tachycardia-induced HF to examine global gene expression in left ventricular myocardium with Affymetrix canine oligonucleotide arrays at various stages after initiation of rapid ventricular pacing (days 3, 7, 14, and 21). The gene expression data were complemented with measurements of action potential duration, conduction velocity, and left ventricular end diastolic pressure, and dP/dt(max) over the time course of rapid ventricular pacing. As a result, we present a phenotype-centered gene association network, defining molecular systems that correspond temporally to hemodynamic and electrical remodeling processes. Gene Ontology analysis revealed an orchestrated regulation of oxidative phosphorylation, ATP synthesis, cell signaling pathways, and extracellular matrix components, which occurred as early as 3 days after the initiation of ventricular pacing, coinciding with the early decline in left ventricular pump function and prolongation of action potential duration. The development of clinically overt left ventricular dysfunction was associated with few additional changes in the myocardial transcriptome. We conclude that the majority of tachypacing-induced transcriptional changes occur early after initiation of rapid ventricular pacing. As the transition to overt HF is characterized by few additional transcriptional changes, posttranscriptional modifications may be more critical in regulating myocardial structure and function during later stages of HF.

[1]  R. Winslow,et al.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: model studies. , 1999, Circulation research.

[2]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[3]  Robert H. Shoemaker,et al.  Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides , 2006, Nucleic Acids Research.

[4]  M. Le Cunff,et al.  Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.

[5]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[6]  Raimond L Winslow,et al.  Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.

[7]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Rosen,et al.  T Wave Changes Persisting After Ventricular Pacing in Canine Heart Are Altered by 4‐Aminopyridine But Not by Lidocaine: Implications With Respect to Phenomenon of Cardiac ‘Memory’ , 1992, Circulation.

[9]  J. Marín-García,et al.  Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. , 2001, Cardiovascular research.

[10]  Vincenzo Lionetti,et al.  Chronic Activation of Peroxisome Proliferator-Activated Receptor-α with Fenofibrate Prevents Alterations in Cardiac Metabolic Phenotype without Changing the Onset of Decompensation in Pacing-Induced Heart Failure , 2007, Journal of Pharmacology and Experimental Therapeutics.

[11]  D. Lacroix,et al.  The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy , 2007, Journal of cardiovascular pharmacology.

[12]  Weike Mao,et al.  Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. , 2004, American journal of physiology. Heart and circulatory physiology.

[13]  David D Spragg,et al.  Mechanisms Underlying Conduction Slowing and Arrhythmogenesis in Nonischemic Dilated Cardiomyopathy , 2004, Circulation research.

[14]  D. Kass,et al.  Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.

[15]  D. Kass,et al.  Repolarization abnormalities, arrhythmia and sudden death in canine tachycardia-induced cardiomyopathy. , 1997, Journal of the American College of Cardiology.

[16]  P. Boekstegers,et al.  TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. , 1997, Molecular and cellular biochemistry.

[17]  Satoru Miyano,et al.  Open source clustering software , 2004 .

[18]  W. Tang,et al.  Pathophysiology of congestive heart failure. , 2003, Reviews in cardiovascular medicine.

[19]  W. Fiers,et al.  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. , 1992, The Journal of biological chemistry.

[20]  Ulrich Mansmann,et al.  Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. , 2006, Journal of the American College of Cardiology.

[21]  G. Tomaselli,et al.  Electrophysiological remodeling in hypertrophy and heart failure. , 1999, Cardiovascular research.

[22]  Dinender K. Singla,et al.  p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. , 2007, American journal of physiology. Heart and circulatory physiology.

[23]  G. Moe,et al.  Akt signaling pathway in pacing-induced heart failure , 2005, Molecular and Cellular Biochemistry.

[24]  M. Dunn,et al.  Protein changes observed in pacing‐induced heart failure using two‐dimensional electrophoresis , 1998, Electrophoresis.

[25]  D. Kass,et al.  Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. , 1999, Circulation research.

[26]  F. Recchia,et al.  Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. , 2007, Physiological genomics.

[27]  S. Vatner,et al.  Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine. , 1999, Circulation.

[28]  H. Hecht,et al.  Electrophysiological Study of Human Heart Muscle , 1962, Circulation research.

[29]  A. Nishiyama,et al.  Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade , 2006, Journal of hypertension.

[30]  R. Tunin,et al.  Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure. , 2006, Journal of molecular and cellular cardiology.

[31]  Joaquín Dopazo,et al.  BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments , 2006, Nucleic Acids Res..

[32]  D. Kass,et al.  Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. , 1996, Circulation research.

[33]  G. Tomaselli,et al.  Regulation of Kv4.3 Current by KChIP2 Splice Variants: A Component of Native Cardiac Ito? , 2002, Circulation.